ID27289A - Penggunaan yang baru - Google Patents
Penggunaan yang baruInfo
- Publication number
- ID27289A ID27289A IDW20002260A ID20002260A ID27289A ID 27289 A ID27289 A ID 27289A ID W20002260 A IDW20002260 A ID W20002260A ID 20002260 A ID20002260 A ID 20002260A ID 27289 A ID27289 A ID 27289A
- Authority
- ID
- Indonesia
- Prior art keywords
- new use
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Addiction (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/071,826 US6277870B1 (en) | 1998-05-04 | 1998-05-04 | Use |
Publications (1)
Publication Number | Publication Date |
---|---|
ID27289A true ID27289A (id) | 2001-03-22 |
Family
ID=22103848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20002260A ID27289A (id) | 1998-05-04 | 1999-05-28 | Penggunaan yang baru |
Country Status (27)
Country | Link |
---|---|
US (2) | US6277870B1 (no) |
EP (1) | EP1079828B1 (no) |
JP (1) | JP2002513757A (no) |
KR (1) | KR20010043266A (no) |
CN (2) | CN1637149A (no) |
AR (1) | AR016217A1 (no) |
AT (1) | ATE249827T1 (no) |
AU (1) | AU770849B2 (no) |
BR (1) | BR9910180A (no) |
CA (1) | CA2331070A1 (no) |
DE (1) | DE69911400T2 (no) |
EE (1) | EE200000640A (no) |
HK (1) | HK1034205A1 (no) |
HU (1) | HUP0102504A3 (no) |
ID (1) | ID27289A (no) |
IL (1) | IL139145A0 (no) |
IS (1) | IS5699A (no) |
MY (1) | MY116027A (no) |
NO (1) | NO20005503L (no) |
PL (1) | PL343923A1 (no) |
RU (1) | RU2225203C2 (no) |
SK (1) | SK284608B6 (no) |
TR (1) | TR200003244T2 (no) |
TW (1) | TW542718B (no) |
UA (1) | UA65617C2 (no) |
WO (1) | WO1999056745A1 (no) |
ZA (1) | ZA200006133B (no) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6277870B1 (en) | 1998-05-04 | 2001-08-21 | Astra Ab | Use |
US20040259909A1 (en) * | 2001-10-16 | 2004-12-23 | Mccarthy Dennis | Treatment of fibromyalgia syndrome |
NZ554913A (en) * | 2001-12-14 | 2009-01-31 | Targacept Inc | Methods and compositions for the treatment of central nervous system disorders |
US7091357B2 (en) * | 2001-12-26 | 2006-08-15 | University Of Kentucky Research Foundation | Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
US20040052928A1 (en) * | 2002-09-06 | 2004-03-18 | Ehud Gazit | Peptides and methods using same for diagnosing and treating amyloid-associated diseases |
US7781396B2 (en) * | 2002-01-31 | 2010-08-24 | Tel Aviv University Future Technology Development L.P. | Peptides directed for diagnosis and treatment of amyloid-associated disease |
US20030162770A1 (en) | 2002-02-22 | 2003-08-28 | Davis Bonnie M. | Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
US20030236287A1 (en) * | 2002-05-03 | 2003-12-25 | Piotrowski David W. | Positive allosteric modulators of the nicotinic acetylcholine receptor |
US7358057B2 (en) | 2002-05-09 | 2008-04-15 | Memory Pharmaceuticals Corporation | QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
WO2004019943A1 (en) | 2002-08-30 | 2004-03-11 | Memory Pharmaceuticals Corporation | Anabaseine derivatives useful in the treatment of neurodegenerative diseases |
EE05516B1 (et) | 2002-09-25 | 2012-02-15 | Memory@Pharmaceuticals@Corporation | Indasoolid bensotiasoolid ja bensoisotiasoolid nende valmistamine ning kasutamine |
US7491699B2 (en) | 2002-12-09 | 2009-02-17 | Ramot At Tel Aviv University Ltd. | Peptide nanostructures and methods of generating and using the same |
WO2004060791A1 (en) | 2003-01-07 | 2004-07-22 | Ramot At Tel Aviv University Ltd. | Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
CA2540407A1 (en) | 2003-09-25 | 2005-03-31 | Tel Aviv University Future Technology Development L.P. | Compositions and methods using same for treating amyloid-associated diseases |
US7625707B2 (en) * | 2003-10-02 | 2009-12-01 | Ramot At Tel Aviv University Ltd. | Antibacterial agents and methods of identifying and utilizing same |
ES2295973T3 (es) | 2003-12-22 | 2008-04-16 | Memory Pharmaceuticals Corporation | Indoles, 1h-indazoles, 1,2-bencisoxazoles, y 1,2-bencisotiazoles, y preparacion y usos de los mismos. |
EP1735306A2 (en) | 2004-03-25 | 2006-12-27 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
DE602005024677D1 (de) | 2004-04-22 | 2010-12-23 | Memory Pharm Corp | Indole, 1h-indazole, 1,2-benzisoxazole, 1,2-benzoisothiazole, deren herstellung und verwendungen |
BRPI0510212A (pt) | 2004-05-07 | 2007-10-16 | Memory Pharm Corp | 1h-indazóis, benzotiazóis, 1,2 - benzoisoxazóis, 1,2-benzoisotiazóis, e cromonas e a preparação e usos dos mesmos |
WO2006006172A2 (en) * | 2004-07-15 | 2006-01-19 | Ramot At Tel Aviv University Ltd. | Use of anti-amyloid agents for treating and typing pathogen infections |
US8568637B2 (en) * | 2004-08-02 | 2013-10-29 | Ramot At Tel-Aviv University Ltd. | Method of forming a fiber made of peptide nanostructures |
WO2006018850A2 (en) | 2004-08-19 | 2006-02-23 | Tel Aviv University Future Technology Development L.P. | Compositions for treating amyloid associated diseases |
US7786086B2 (en) | 2004-09-08 | 2010-08-31 | Ramot At Tel-Aviv University Ltd. | Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same |
RU2418797C2 (ru) | 2004-12-22 | 2011-05-20 | Мемори Фармасьютиклз Корпорейшн | Лиганды никотинового рецептора альфа-7, их получение и применение |
JP5833804B2 (ja) * | 2005-04-13 | 2015-12-16 | ニューラクソン,インコーポレーテッド | Nos阻害活性を有する置換インドール化合物 |
US8106066B2 (en) | 2005-09-23 | 2012-01-31 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
WO2007043048A2 (en) * | 2005-10-11 | 2007-04-19 | Ramot At Tel Aviv University Ltd. | Self-assembled fmoc-ff hydrogels |
US7879212B2 (en) * | 2005-11-03 | 2011-02-01 | Ramot At Tel-Aviv University Ltd. | Peptide nanostructure-coated electrodes |
US20070134169A1 (en) * | 2005-12-11 | 2007-06-14 | Rabinoff Michael D | Methods for smoking cessation or alcohol cessation or other addiction cessation |
CN101466709B (zh) * | 2006-04-13 | 2013-03-20 | 轴突公司 | 具有nos抑制活性的1,5和3,6-取代的吲哚化合物 |
US8314119B2 (en) * | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
BRPI0820632A2 (pt) * | 2007-11-16 | 2015-06-16 | Neuraxon Inc | Compostos de indol e métodos para tratamento de dor visceral |
WO2009064505A1 (en) * | 2007-11-16 | 2009-05-22 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods for treating visceral pain |
ES2396300T3 (es) | 2008-11-19 | 2013-02-20 | Envivo Pharmaceuticals, Inc. | Tratamiento de trastornos cognitivos con (R)-7-cloro-N-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma |
CN102802620A (zh) * | 2009-05-11 | 2012-11-28 | 英维沃医药有限公司 | 使用某种α-7烟酸受体与乙酰胆碱酯酶抑制剂结合治疗认知障碍 |
WO2011146511A1 (en) | 2010-05-17 | 2011-11-24 | Envivo Pharmaceuticals, Inc. | A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
NZ609761A (en) | 2010-09-23 | 2015-10-30 | Abbvie Bahamas Ltd | Monohydrate of an azaadamantane derivative |
AU2013259871A1 (en) | 2012-05-08 | 2014-11-20 | Forum Pharmaceuticals Inc. | Methods of maintaining, treating or improving cognitive function |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2649009B1 (fr) * | 1989-07-03 | 1991-10-11 | Oreal | Procede de teinture des fibres keratiniques a base de monohydroxyindole et de 5,6-dihydroxyindole et composition mise en oeuvre |
US5272155A (en) * | 1991-12-05 | 1993-12-21 | Abbott Laboratories | (+)-2-methylpiperidine as modulator of cholinergic systems |
WO1995007078A1 (en) * | 1993-09-10 | 1995-03-16 | Cytomed, Inc. | Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists |
CA2196995C (en) * | 1994-08-24 | 2008-05-13 | Michael Balestra | Spiro-azabicyclic compounds useful in therapy |
SE9600683D0 (sv) * | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
US6277870B1 (en) | 1998-05-04 | 2001-08-21 | Astra Ab | Use |
-
1998
- 1998-05-04 US US09/071,826 patent/US6277870B1/en not_active Expired - Fee Related
-
1999
- 1999-04-21 TW TW088106373A patent/TW542718B/zh not_active IP Right Cessation
- 1999-04-22 AR ARP990101861A patent/AR016217A1/es unknown
- 1999-04-28 KR KR1020007012221A patent/KR20010043266A/ko not_active Application Discontinuation
- 1999-04-28 CA CA002331070A patent/CA2331070A1/en not_active Abandoned
- 1999-04-28 IL IL13914599A patent/IL139145A0/xx unknown
- 1999-04-28 WO PCT/SE1999/000700 patent/WO1999056745A1/en not_active Application Discontinuation
- 1999-04-28 AT AT99948542T patent/ATE249827T1/de not_active IP Right Cessation
- 1999-04-28 UA UA2000126907A patent/UA65617C2/uk unknown
- 1999-04-28 BR BR9910180-7A patent/BR9910180A/pt not_active IP Right Cessation
- 1999-04-28 SK SK1570-2000A patent/SK284608B6/sk unknown
- 1999-04-28 DE DE69911400T patent/DE69911400T2/de not_active Expired - Fee Related
- 1999-04-28 EP EP99948542A patent/EP1079828B1/en not_active Expired - Lifetime
- 1999-04-28 TR TR2000/03244T patent/TR200003244T2/xx unknown
- 1999-04-28 RU RU2000130209/15A patent/RU2225203C2/ru not_active IP Right Cessation
- 1999-04-28 CN CNA2004100880671A patent/CN1637149A/zh active Pending
- 1999-04-28 PL PL99343923A patent/PL343923A1/xx not_active Application Discontinuation
- 1999-04-28 AU AU43023/99A patent/AU770849B2/en not_active Ceased
- 1999-04-28 CN CN99805760A patent/CN1299279A/zh active Pending
- 1999-04-28 EE EEP200000640A patent/EE200000640A/xx unknown
- 1999-04-28 JP JP2000546771A patent/JP2002513757A/ja active Pending
- 1999-04-28 HU HU0102504A patent/HUP0102504A3/hu unknown
- 1999-05-04 MY MYPI99001750A patent/MY116027A/en unknown
- 1999-05-28 ID IDW20002260A patent/ID27289A/id unknown
-
2000
- 2000-10-30 ZA ZA200006133A patent/ZA200006133B/en unknown
- 2000-11-01 NO NO20005503A patent/NO20005503L/no not_active Application Discontinuation
- 2000-11-01 IS IS5699A patent/IS5699A/is unknown
-
2001
- 2001-03-20 US US09/812,269 patent/US6861443B2/en not_active Expired - Fee Related
- 2001-07-17 HK HK01105008A patent/HK1034205A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID27289A (id) | Penggunaan yang baru | |
ID26308A (id) | Dihidropirimidin baru yang tersubstitusi secara 2-heterosiklik | |
ID24959A (id) | Senyawa-senyawa trisiklik yang baru | |
ID15881A (id) | Oksazolidinan tersubstitusi yang baru | |
ID24417A (id) | Ariloksi-alkil-dialkilamina yang baru | |
ID27263A (id) | Dihidropirimidina baru | |
ID17686A (id) | Fotoinisiator alpha-aminoasetofenon baru | |
ID28110A (id) | Surfaktan alkilbenzenasulfonat yang disempurnakan | |
ID21881A (id) | Turunan-turunan baru pirazol tersubstitusi | |
ID24555A (id) | Popok sekali pakai | |
ID15840A (id) | Turunan-turunan 19-nor-pregnena baru | |
ID27690A (id) | Senyawa-senyawa antibakteri isoksazolinon baru | |
ID28286A (id) | Antibiotik-antibiotik makrolida baru | |
ID23083A (id) | Popok sekali pakai | |
ID18431A (id) | Senyawa-senyawa baru | |
ID21525A (id) | Komposisi bedak baru | |
ID16660A (id) | Senyawa-senyawa b-laktam monosiklik baru | |
ID24716A (id) | Formulasi baru | |
ID26299A (id) | Herbisida baru | |
ID22198A (id) | Keton-keton yang baru | |
ID23177A (id) | Turunan pirimidin baru | |
NO20010154L (no) | Brønnhulls-strekksvivelovergang | |
ID19542A (id) | Pengobatan baru | |
ID18262A (id) | Turunan-turunan baru piranosida | |
ID27096A (id) | Komposisi farmasi yang baru |